Benefits of early statin treatment in patients with acute myocardial infarction
Numerous clinical trials have shown that HMG CoA reductase inhibitor (statin) therapy reduces the risk of myocardial infarction (MI), stroke, and mortality in patients with cardiovascular disease.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.